Objective.-This study was conducted to investigate sex differences in the prevalence and clinical presentation of migraine and probable migraine in a general population-based sample.
INTRODUCTION
Migraine is a common neurological disorder and can pose considerable personal and social burden. 1 With respect to sex differences, women, unlike men, experience sex hormone changes, such as estrogen withdrawal, that are known to be closely related to migraine occurrence, 2 and a significantly higher prevalence of migraine and probable migraine (PM) among women has been persistently documented around the world. [3] [4] [5] In addition, studies have shown that the number of days with headache attacks in the previous 3 months and of days with disability due to headache were higher in women migraineurs than in men. 2, 6, 7 Furthermore, psychological comorbidities such as anxiety and/or depression are more frequently noted in women than in men. 8 PM is a type of migraine that meets all but 1 criteria of migraine. Owing to its disabling symptoms, individuals with PM experience similar or only somewhat lesser disability than those with migraine. 9 As with migraine, epidemiological studies have persistently shown a preponderance of women among individuals affected by PM. 4, 6 Combining the prevalence of migraine and PM in women, approximately one-fourth of all women suffer from migraine or PM in any given year. However, relatively little data on sex differences linked to headache characteristics, accompanying symptoms, the impact of headache, and the common comorbidities of migraine and PM are available in Asia, an area that includes more than half of the world's population. 10 Furthermore, the prevalence and clinical characteristics of migraine and PM in Asian countries are somewhat different from those observed in Western countries. 9, 11, 12 We hypothesized that clinical features, such as frequency, intensity, impact, and comorbidities, particularly in anxiety and depression, of migraine and PM would be more frequent in women than men. This study aimed to investigate differences in prevalence, clinical symptoms, impact of headache, and comorbidities of migraine and PM associated with sex, using a Korean nationwide population-based sample.
MATERIALS AND METHODS
Survey.-The Korean Headache-Sleep Study (KHSS) is a nationwide cross-sectional study on headaches and sleep characteristics among adults (19-69 years old). The detailed protocol and methods of the KHSS have been described elsewhere. 13 Briefly, the KHSS used 2-stage clustered random sampling methods, and its study population was selected based on the distribution of the general population of Korea (with the exclusion of Jeju island). 13 To prevent interest bias, we explained to all participants that our survey theme was focused on social health issues rather than on neurological disorders such as headache or sleep problems. None of the interviewers were medically related professionals or were members of Gallup Korea (ie, the organization that conducted the study). The survey was performed using a 3-part questionnaire during a face-to-face interview. The first part assessed demographic and socioeconomic characteristics (9 questions), the second part established a headache profile, which was designed to comply with ICHD-2 criteria (13 questions), and the third part involved questions about information regarding the characteristics of headache and sleep, anxiety, and depression. 15 Participants who satisfied all of the above criteria were classified as migraineurs. If one of the above criteria was not satisfied; the case was classified as code 1.5 PM. Because code 1.2.1 migraine with aura and code 1.5.2 PM with aura are difficult to define accurately in an epidemiological study design and using questionnaire survey methods, we did not evaluate the presence of an aura.
14 Therefore, our study's migraineurs include cases of both code 1.1 migraine without aura and code 1.2 migraine with aura, 14, 15 and probable migraineurs include cases of both code 1.5.1 PM without aura and code 1.5.2 PM with aura. 14, 15 Our study questionnaire showed a sensitivity of 75.0% and a specificity of 88.2% when compared with the doctor's diagnosis of migraine and PM made by telephone interview. 12 When tension-type headache and PM were diagnosed simultaneously, a diagnosis of tension-type headache was made. Definition of Anxiety and Depression.-The Goldberg Anxiety Scale, which includes 4 screening items and 5 supplementary items, was used for the diagnosis of anxiety. 16 Participants who provided positive answers to more than 2 items among the screening items and more than 5 items among all scale items were classified as individuals with anxiety. The Korean version of the Goldberg Anxiety Scale was validated in previous studies (sensitivity of 82.0% and specificity of 94.4%). 17, 18 The
Patient Health Questionnaire-9 (PHQ-9) was applied to investigate the presence of depression. 19 In this scoring system, the presence of depression was defined as achieving a score of 10 points or more. 19 The Korean version of the PHQ-9 was also validated in previous studies (sensitivity of 81.1% and specificity of 89.9%). 20 Furthermore, headache frequency per month and average duration (hours) of most severe form of headache were also estimated, and the visual analog scale (VAS, 0 to 10 scales) for headache intensity as well as the Headache Impact Test-6 (HIT-6) for quality of life were administered. Statistical Analyses.-Statistical analysis was performed using the SPSS 22.0 (IBM, Armonk, NY, USA) software program. No statistical power calculation was conducted prior to the study, as the sample size was based on the available data. For the assessment of sex differences in the characteristics of migraine and PM, the Kolmogorov-Smirnov test was used to check for normal distributions for continuous variables. If variables showed a normal distribution, an independent t-test was then used. If variables were not normally distributed, the Mann-Whitney U-test was applied. Categorical variables were compared using a chi-square test or Fisher's exact test. The 95% confidence interval was calculated as mean ± 1.96 × (standard deviation/ √ sample number using SPSS. A P value < .05 in 2-tailed tests was considered statistically significant.
RESULTS
Survey.-We interviewed 7430 people, and 3114 of these individuals agreed to participate in our study (rejection rate, 58.1%). Among these, 419 withdrew their participation during the interview. Ultimately, 2695 people completed our survey (cooperation rate, 36.3%) (Fig. 1) . The characteristics of this data set, ie, sex, age distribution, residence size, and education level, did not differ from those of the total population of Korea (Supplementary Table S1 As for age, the migraine prevalence in women peaked during their 30s and reached its lowest level in women in their 50s. In contrast, the migraine prevalence in men was highest in men in their 40s and lowest in men in their 60s (Fig. 2A) . The overall womento-men ratio for migraine prevalence was 2.9 (95% confidence interval [CI] = 2.1-4.6), highest in participants in their 60s (6.1), followed by participants in their 20s (5.1) and 30s (3.2). The age groups of participants in their 40s and 50s showed the lowest womento-men ratio (2.1).
The PM prevalence was at its highest level in participants in their 40s and lowest in participants in their 50s (Fig. 2B) . Among male participants, the PM prevalence was highest in those in their 30s and lowest in those in their 60s. The overall women-to-men ratio for PM prevalence was 1.8 (95% CI = 1.6-2.4), highest in participants in their 60s (2.5) and followed by participants in their 20s (2.0), 40s (2.0), and 30s (1.7). 
DISCUSSION
The main findings of the present study are as follows: 1) Migraine and PM are more prevalent in women than men in a Korean general population-based sample; 2) The frequencies of headache Data are presented as mean ± standard deviation or number (%). characteristics and accompanying symptoms do not significantly differ between women and men participants with migraine and PM, except for nausea in PM; and 3) Women with PM in this sample experienced more frequent headaches, more severe headache intensities, and higher-impact headaches than men with PM. Among participants with migraine, headache frequency, headache intensity, and the impact of headache did not differ significantly between women and men. The present study compared the prevalence, clinical presentation, and impact of headache in migraine and PM between women and men and confirmed the existing data on the preponderance of women in individuals affected by migraine. Epidemiological studies on headaches have demonstrated that women have an approximately 3 times higher risk of having migraine than men. 7, 21, 22 A significant preponderance in women for all the subtypes of migraine, including migraine without aura, migraine with aura, and migraine aura without headache has also been demonstrated. 3 Our findings are in agreement with the previously reported women-to-men migraine prevalence ratio of 2.9. Several studies have investigated the sex-specific prevalence of PM and have shown that women are predominant in groups of individuals affected by PM. A study in Singapore reported a prevalence of 7.5% and 4.7% in women and men, respectively.
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A population-based study in France reported that 12.2% of women and 7.8% of men were classified as having PM. 5 An American study demonstrated a prevalence of PM in women of 15.9% and in men of 12.2%. Therefore, the women-to-men ratio of PM prevalence ranges from 1.3 to 1.6. 4 The similarities in the women-to-men ratio in PM prevalence (1.8) between the present study and previous studies indicates that we adequately evaluated the differences in migraine and PM between women and men.
The women-to-men ratios of migraine and PM prevalence varied greatly with age in the present study, with ratios being highest in age groups of individuals in their 60s and lowest in groups in their 30s. These findings stem from unequal changes in the prevalence of migraine and PM with age in women and men. The prevalence of migraine and PM was at its highest level between the ages of 20 and 40. After the age of 50, both migraine and PM prevalence decrease, but the decrease is more prominent in men than women. 24 These sex-specific differences in migraine prevalence have been explained by differences in hormones. High levels of estrogen and estrogen withdrawal during the menstrual period have been proposed as an explanation for the high prevalence of migraine in women during their reproductive years. 25 Several studies have addressed the anti-nociceptive role of testosterone in migraine. 26 After the age of 50, the decrease in sex hormones occurred in both women and men. Nevertheless, the levels and profiles of sex hormones decline differed. 27 Another possible explanation for the sex-specific differences in migraine is differences in the brain. Significant structural and neural circuitry differences have been reported between the brains of women and men with migraine. 28 Therefore, the differences in sex hormones and brains might contribute to unequal changes of migraine prevalence in women and men with age, and result in significant variation in the women-to-men ratio of the prevalence of migraine. Reports on differences in sex hormones and brains among individuals with PM are currently scarce, and further studies are needed. The present study shows that headache frequency and headache intensity did not significantly differ between women and men with migraine. These findings are similar to previous studies in the United States and Germany. 6, 29 Nevertheless, headache frequency and headache intensity of PM were found to be more prominent in women than men in our study. These findings are contradictory to a previous report that headache frequency and headache intensity of PM are not significantly different between women and men. 6 One possible explanation for the discrepancy is ethnic differences in headache characteristics of migraine and PM between Asian and Western countries. Most previous sex-specific studies of migraine or PM were conducted in Western countries. 2, 6, 7 Studies in Western countries showed higher prevalence of migraine, lower PM prevalence, and longer attack duration compared to those of Asian countries. 12, 23, 30, 31 As missing typical headache duration criteria are the most common cause for a PM diagnosis, shorter attack durations may contribute to a higher PM prevalence in Asian countries. 5, 9 Therefore, as individuals with migraine in Asian countries have relatively severe symptoms among individuals with migrainous headache (migraine and PM), sex differences in headache characteristics and the impact of headache may not be apparent. Differences in survey and sampling methods could be another possible explanation. Nevertheless, studies on sex differences in the clinical presentation of PM are currently scarce and further studies are needed. The prominence of headache-related disability in women has been consistently noted. The World Health Organization recognized migraine as the fifth leading cause of years lived with disability for women and the seventh cause for men. 22 A large population-based survey in the United States demonstrated that women reported more headache-related disability than men. 6 Although the present study did not directly assess headache-related disability, we investigated the impact of headache using the HIT-6. The Headache Impact Test-6 score is closely related to the Migraine Disability Assessment (MIDAS) score and the MIDAS is a valid instrument for assessing headache-related disability. 32 The present study yielded results similar to those reported in previous studies in that women with PM experienced a greater impact of headache than men. Nevertheless, the impact of headache (HIT-6 score) did not differ significantly between women and men. Discrepancies associated with sex in the impact of headache between the present study and previous studies may be attributed to differences in ethnicity, geography, or the assessing instruments.
As the prevalence of PM is approximately twice that of migraine in the KHSS data, the overall impact of headache caused by migrainous headaches would be more prominent in women. 14, 33 Several studies reported that migraine attack duration significantly varies by geographical factors and ethnicity. [34] [35] [36] The shorter attack durations of PM compared to those observed for migraine could stem from the fact that missing the criterion of typical duration is the most common reason for a PM diagnosis in Asian and European countries. 5, 9 Accordingly, attack durations of migraine and PM might differ in some subgroups. Nevertheless, attack durations of migraine and PM did not significantly differ between women and men in the present study. In our study, associated symptoms such as nausea, vomiting, photophobia, and phonophobia did not differ between women and men participants with migraine. In addition, there was no difference in associated symptoms of PM between women and men except for nausea. Previous studies have reported inconsistent results for the preponderance of migraine accompanying symptoms according to sex. There are reports that the presence and severity of the associated symptoms are more common in women than in men, 6, 37 while other studies did not report any differences. 38, 39 In our study, nausea was more common in women in the PM group, supporting previous findings. 6, 37 Further study on the mechanisms resulting in sex differences in migraine-associated symptoms are however necessary, as this research represents an epidemiological study.
The present study has several limitations. First, we used a questionnaire for migraine rather than a specially validated questionnaire for PM. Nevertheless, the questionnaire was based on the ICHD-2 and we diagnosed PM based on ICHD-2 criteria in the present study. The questionnaire showed a high sensitivity and specificity for the diagnosis of migraine. 12 Second, we did not include covariates such as medical consultation and treatment for headache in our analyses. Proper diagnosis and treatment may alleviate symptoms of migraine and PM and could reduce the impact of headache. However, only a small proportion of individuals with migraine or headache visit doctors and use prescribed drugs for their headaches in Korea. 12 Third, because people who did not agree to join in our study were excluded, we did not have information such as age, sex, and demographic factors for those who did not agree to participate. Furthermore, our data set had a modest cooperation rate. However, we used a 2-stage clustered random sampling, proportional to the population distribution of Korea. Moreover, the distribution of age, sex, size of residential area, and educational level of participants in our data set did not differ from the Korean general population. In addition, the prevalence of migraine, PM, anxiety, and depression in the KHSS were similar to those reported in previous studies. 13, 14 Fourth, migraine subclassifications such as those with aura that were not studied here could account for the differences in clinical impact and sex. Fifth, health care utilization among subjects with headache was not studied, but could have an impact on quality of life and disability. Lastly, although we used the data from the KHSS, a population-based study with a large sample size, the statistical power was limited in some of our subgroup analyses.
The strengths of the present study include its large sample size, the population-based format, the proportional population distribution, the assessment of both migraine and PM, and the diagnosis based on the ICHD-2. Furthermore, we analyzed comorbidity and associated symptoms, which are commonly associated with migraine in a general population setting, and compared the frequency and intensity of migraine and PM according to sex.
In conclusion, although the frequency, intensity, and impact of headache did not differ between women and men with migraine, sex differences associated with the characteristics of headache were found in participants with PM. Our findings suggest that women with PM need more intensive evaluation and treatment than men with PM. 
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